James Corbett - Dec 22, 2021 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role
Director
Signature
/s/ Donna Shiroma, by power of attorney
Stock symbol
RCEL
Transactions as of
Dec 22, 2021
Transactions value $
$0
Form type
4
Date filed
12/27/2021, 03:30 PM
Previous filing
Dec 27, 2021
Next filing
Dec 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCEL Common Stock Award +8.68K 8.68K Dec 22, 2021 Direct F1, F2
transaction RCEL Common Stock Award +4.35K +50.14% 13K Dec 22, 2021 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCEL Stock Options (Right to Buy) Award $0 +4.93K $0.00 4.93K Dec 22, 2021 Common Stock 4.93K $12.18 Direct F4
transaction RCEL Stock Options (Right to Buy) Award $0 +2.55K $0.00 2.55K Dec 22, 2021 Common Stock 2.55K $12.18 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of Restricted Stock Units ("RSUs"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest in three equal annual installments on the first, second and third anniversaries of the grant date.
F2 Includes unvested RSUs.
F3 Represents an award of RSUs that vest on the date 12 months following the grant date.
F4 These Stock Options vest in three equal annual installments on the first, second and third anniversaries of the grant date.
F5 These Stock Options vest on the date 12 months following the grant date.